Antiphospholipid antibodies and the antiphospholipid antibody syndrome (Q73086663)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039162 AND SRC:MED&resulttype=core&format=json

1 November 2019

review article

1 reference

title

Antiphospholipid antibodies and the antiphospholipid antibody syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039162 AND SRC:MED&resulttype=core&format=json

1 November 2019

author name string

G T Nahass

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039162 AND SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039162 AND SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039162 AND SRC:MED&resulttype=core&format=json

1 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039162 AND SRC:MED&resulttype=core&format=json

1 November 2019

issue

2 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039162 AND SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

149-68; quiz 169-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039162 AND SRC:MED&resulttype=core&format=json

Biologically false positive serologic tests for syphilis; type, incidence, and cause

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin response in acute infections

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The natural history of systemic lupus erythematosus: An approach to its study through chronic biologic false positive reactors

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Laboratory identification of the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

1 reference

7 January 2021

Prothrombin activation on phospholipid membranes with positive electrostatic potential

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

"Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Autoantibodies directed against the epidermal growth factor‐like domains of thrombomodulin inhibit protein C activation in vitro

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antibodies against platelet-activating factor in patients with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Inhibition of phospholipid-dependent coagulation reactions by 'antiphospholipid antibodies': possible modes of action

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Purification of antiphospholipid antibodies using a new affinity method

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Clinical manifestations and laboratory findings in patients with lupus anticoagulants.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The Varied Sensitivity of Partial Thromboplastin and Prothrombin Time Reagents in the Demonstration of the Lupus-Like Anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Comparison of two simple tests for the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Comparison of laboratory tests used for identification of the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Simplified screening procedure for detecting lupus inhibitor

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Clinical implications of laboratory testing for the thrombophilic disorders

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Interlaboratory variation in antiphospholipid antibody testing

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

False-positive test result for IgM anticardiolipin antibody due to IgM rheumatoid factor

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural Patterns

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Frequency and risk factors

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Circulating anticoagulant in systemic lupus erythematosus: clinical manifestations

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Lupus anticoagulant, thrombosis and thrombocytopenia in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibody and complement

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Isotype profile and clinical relevance of anticardiolipin antibodies in Sjogren's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies: occurrence in Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

A collagen disorder of the nervous system presenting as multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

ANTI-CARDIOLIPIN ANTIBODIES IN VIRAL INFECTION

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies in lyme disease

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Effective inhibition of cardiolipin-binding antibodies in gram-negative infections by bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Circulating coagulation inhibitors in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Circulating anticoagulant in patients seropositive for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies associated with HTLV-III infection.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Skin Necrosis Indicating Antiphospholipid Syndrome in Patient With AIDS

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibodies associated with clozapine treatment

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibodies in a sample of chronic schizophrenics receiving neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Familial occurrence of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Hla—dr antigens and anticardiolipin antibodies in northern italian systemic lupus erythematosus patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Skin lesions associated with circulating lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The Prosser-White oration 1983. Connective tissue disease and the skin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The spectrum of livedo reticularis and anticardiolipin antibodies.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Clinical and immunologic features of livedo reticularis in lupus: a case-control study

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Livedo reticularis. Signs in the skin of disturbance of blood viscosity and of blood flow

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

PERIPHERAL VASCULAR SYNDROMES ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Skin ulcer as the presenting symptom of primary antiphospholipid syndrome--resolution with anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Pyoderma-gangraenosum-like ulcers associated with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Widespread cutaneous necrosis associated with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Cutaneous necrosis associated with the lupus anticoagulant.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Widespread cutaneous necrosis in a patient with rheumatoid arthritis associated with anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibodies and necrotizing purpura.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Gangrene developing after minor surgery in a patient with undiagnosed systemic lupus erythematosus and lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Thrombotic skin disease as a marker of the anticardiolipin syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Thrombosis in patients with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Degos' disease: association with anticardiolipin antibodies and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Sneddon's syndrome (livedo reticularis and cerebral thrombosis) with livedo vasculitis and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Livedo reticularis, porcelain-white scars, and cerebral thromboses

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Unfading acral microlivedo. A discrete marker of thrombotic skin disease associated with antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome--a report of two cases

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Subungual splinter haemorrhages: a new sign of the antiphospholipid coagulopathy?

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Multiple subungual splinter hemorrhages in the antiphospholipid syndrome: a report of five cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Corticosteroid-associated blue toe syndrome: role of antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Neurological syndromes associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Neurological disease associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The antiphospholipid syndrome: prevalence among patients with stroke and transient ischemic attacks

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Amaurosis fugax associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibody syndrome presenting with complex partial seizures and transient ischaemic attacks due to widespread small cerebral arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibodies and Sneddon's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Sneddon's syndrome and primary antiphospholipid syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Immunosuppressive therapy and Sneddon's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Sneddon's syndrome and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibodies and thrombosis

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Risk factors for thrombosis in lupus patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Hepatic infarction in a patient with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Arterial occlusion causing large bowel infarction--a reflection of clotting diathesis in SLE

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Aortic arch syndrome associated with anticardiolipin antibodies and the lupus anticoagulant: comment on Ferrante paper

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Bilateral adrenal infarction, hypoadrenalism and splinter haemorrhages in the 'primary' antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Renal manifestations of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Intracardiac thrombus in systemic lupus erythematosus associated with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Dissolution of intracardiac mass lesions in the primary antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Diastolic dysfunction is a feature of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antibodies to phospholipids and nuclear antigens in patients with repeated abortions

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibodies in pregnancy: prevalence and clinical associations

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibodies in pre‐eclamptic women: Relation to growth retardation and neonatal outcome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Antiphospholipid antibodies and recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Thrombosis in the Antiphospholipid-Antibody Syndrome

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Molecular and cellular biology of blood coagulation

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanism

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Plasma exchange and the anticardiolipin syndrome in pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Fish oil derivatives as a prophylaxis of recurrent miscarriage associated with antiphospholipid antibodies (APL): a pilot study

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Fetal survival after prednisone suppression of maternal lupus-anticoagulant

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Lupus anticoagulant and pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(97)70274-3

7 January 2021

10.1016/S0190-9622(97)70274-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039162 AND SRC:MED&resulttype=core&format=json

1 November 2019

1 reference